Search Results - "Dévédec, Sylvia Le"

Refine Results
  1. 1

    A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells by Lameijer, Lucien N., Ernst, Daniël, Hopkins, Samantha L., Meijer, Michael S., Askes, Sven H. C., LeDévédec, Sylvia E., Bonnet, Sylvestre

    Published in Angewandte Chemie International Edition (11-09-2017)
    “…We describe two water‐soluble ruthenium complexes, [1]Cl2 and [2]Cl2, that photodissociate to release a cytotoxic nicotinamide phosphoribosyltransferase…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration by Yizhak, Keren, Le Dévédec, Sylvia E, Rogkoti, Vasiliki Maria, Baenke, Franziska, de Boer, Vincent C, Frezza, Christian, Schulze, Almut, van de Water, Bob, Ruppin, Eytan

    Published in Molecular systems biology (01-08-2014)
    “…Over the last decade, the field of cancer metabolism has mainly focused on studying the role of tumorigenic metabolic rewiring in supporting cancer…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Cell viability imaging in tumor spheroids via DNA binding of a ruthenium(II) light-switch complex by Ramu, Vadde, Wijaya, Lukas S, Beztsinna, Nataliia, Van de Griend, Corjan, van de Water, Bob, Bonnet, Sylvestre, Le Dévédec, Sylvia E

    “…The famous ''light-switch'' ruthenium complex [Ru(bpy) (dppz)](PF ) (1) has been long known for its DNA binding properties . However, the biological utility of…”
    Get more information
    Journal Article
  10. 10

    Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy by Koedoot, Esmee, Wolters, Liesanne, Smid, Marcel, Stoilov, Peter, Burger, Gerhard A., Herpers, Bram, Yan, Kuan, Price, Leo S., Martens, John W. M., Le Dévédec, Sylvia E., van de Water, Bob

    Published in Scientific reports (31-03-2021)
    “…Screening for effective candidate drugs for breast cancer has shifted from two-dimensional (2D) to three-dimensional (3D) cultures. Here we systematically…”
    Get full text
    Journal Article
  11. 11

    Lipidomic profiling of triple-negative breast cancer cells reveals distinct metabolic signatures associated with EpCAM expression by Huang, Xiaoyue, Di, Xinyu, Zuiderwijk, Melissa Celine, Zhang, Lu, Leegwater, Hanneke, Davidse, Sam, Kindt, Alida, Harms, Amy, Hankemeier, Thomas, Le Dévédec, Sylvia E., Ali, Ahmed

    Published in Talanta (Oxford) (01-02-2025)
    “…Lipid metabolism is essential at all stages of cancer progression, particularly for triple-negative breast cancer (TNBC) the deadliest cancer subtype for women…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer by Yizhak, Keren, Gaude, Edoardo, Le Dévédec, Sylvia, Waldman, Yedael Y, Stein, Gideon Y, van de Water, Bob, Frezza, Christian, Ruppin, Eytan

    Published in eLife (21-11-2014)
    “…Utilizing molecular data to derive functional physiological models tailored for specific cancer cells can facilitate the use of individually tailored…”
    Get full text
    Journal Article
  14. 14

    A Chemical Biological Approach to Study G Protein-Coupled Receptors: Labeling the Adenosine A1 Receptor Using an Electrophilic Covalent Probe by Beerkens, Bert L. H., Koç, Çağla, Liu, Rongfang, Florea, Bogdan I., Le Dévédec, Sylvia E., Heitman, Laura H., IJzerman, Adriaan P., van der Es, Daan

    Published in ACS chemical biology (18-11-2022)
    “…G protein-coupled receptors (GPCRs) have been known for decades as attractive drug targets. This has led to the development and approval of many ligands…”
    Get full text
    Journal Article
  15. 15

    Single-cell metabolomics by mass spectrometry: ready for primetime? by Zhang, Congrou, Le Dévédec, Sylvia E, Ali, Ahmed, Hankemeier, Thomas

    Published in Current opinion in biotechnology (01-08-2023)
    “…Single-cell metabolomics (SCMs) is a powerful tool for studying cellular heterogeneity by providing insight into the differences between individual cells. With…”
    Get full text
    Journal Article
  16. 16

    Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer by Dekker, Yasmin, Le Dévédec, Sylvia E, Danen, Erik H. J, Liu, Qiuyu

    Published in Genes (03-09-2022)
    “…Even though breast cancer is the most diagnosed cancer among women, treatments are not always successful in preventing its progression. Recent studies suggest…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury by Wijaya, Lukas S, Gabor, Attila, Pot, Iris E, van de Have, Luca, Saez-Rodriguez, Julio, Stevens, James L, Le Dévédec, Sylvia E, Callegaro, Giulia, van de Water, Bob

    Published in Toxicological sciences (28-02-2024)
    “…Abstract Drug-induced liver injury (DILI) remains the main reason for drug development attritions largely due to poor mechanistic understanding. Toxicogenomic…”
    Get full text
    Journal Article
  19. 19

    Co-regulated gene expression of splicing factors as drivers of cancer progression by Koedoot, Esmee, Smid, Marcel, Foekens, John A., Martens, John W. M., Le Dévédec, Sylvia E., van de Water, Bob

    Published in Scientific reports (02-04-2019)
    “…Splicing factors (SFs) act in dynamic macromolecular complexes to modulate RNA processing. To understand the complex role of SFs in cancer progression, we…”
    Get full text
    Journal Article
  20. 20